Safety and Efficacy of AST-120 in Mild to Moderate Crohn's Patients With Fistulas
Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the safety and effectiveness of the experimental
drug AST-120 in treating patients with mild to moderately severe Crohn's disease who have
fistulas. The study will test whether or not patients receiving AST-120 experience a greater
reduction in number of draining fistulas and improvement of their other Crohn's disease
symptoms versus patients who receive placebo (material that does not contain any active
medication).